المؤلفون: Brada LJH; Department of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center, Utrecht, The Netherlands.; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Walma MS; Department of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center, Utrecht, The Netherlands.; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Daamen LA; Department of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center, Utrecht, The Netherlands., van Roessel S; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., van Dam RM; Department of Surgery, Maastricht UMC+, Maastricht, The Netherlands., de Hingh IH; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Liem MLS; Department of Surgery, Medical Spectrum Twente, Enschede, The Netherlands., de Meijer VE; Department of Surgery, UMC Groningen, Groningen, The Netherlands., Patijn GA; Department of Surgery, Isala, Zwolle, The Netherlands., Festen S; Department of Surgery, OLVG, Amsterdam, The Netherlands., Stommel MWJ; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands., Bosscha K; Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands., Yung Nio C; Department of Radiology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Wessels FJ; Department of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Utrecht, The Netherlands., de Vries JJJ; Department of Radiology, Cancer Center Amsterdam, Amsterdam UMC, VU University, Amsterdam, The Netherlands., van Lienden KP; Department of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Utrecht, The Netherlands., Bruijnen RC; Department of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Utrecht, The Netherlands., Los M; Department of Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Regional Academic Cancer Center Utrecht, Utrecht, The Netherlands., Mohammad NH; Department of Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein, Regional Academic Cancer Center Utrecht, Utrecht, The Netherlands., Wilmink HW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Busch OR; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Besselink MG; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Quintus Molenaar I; Department of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center, Utrecht, The Netherlands., van Santvoort HC; Department of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center, Utrecht, The Netherlands.

مؤلفون مشاركون: Dutch Pancreatic Cancer Group

المصدر: Journal of surgical oncology [J Surg Oncol] 2021 Sep; Vol. 124 (4), pp. 589-597. Date of Electronic Publication: 2021 Jun 11.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Nomograms*, Adenocarcinoma/*mortality , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Pancreatectomy/*mortality , Pancreatic Neoplasms/*mortality, Adenocarcinoma/pathology ; Adenocarcinoma/therapy ; Aged ; Combined Modality Therapy ; Female ; Fluorouracil/therapeutic use ; Follow-Up Studies ; Humans ; Irinotecan/therapeutic use ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Oxaliplatin/therapeutic use ; Pancreatic Neoplasms/pathology ; Pancreatic Neoplasms/therapy ; Prognosis ; Prospective Studies ; Survival Rate